Racial, ethnic disparities emerge after neoadjuvant therapy for gastric cancer

There are significant differences in response to treatment and survival outcomes for certain racial and ethnic groups among patients with resected stage II or stage III gastric cancer, study findings published in JAMA Network Open showed.
Most notably, researchers observed that patients who identify as Asian or Black responded favorably to neoadjuvant therapy, whereas Asian and Hispanic patients appeared independently associated with improved OS compared with Black and white patients.
“To our knowledge, this is the first large nationwide retrospective cohort study evaluating the

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart